2015年12月27日
A new app can summon a translator for over 5,000 languages on demand
By rover08
In just a few days, CSOFT International introduces Stepes, their latest development and the world’s first mobile translation app. Translation industry leader and globalization expert, CSOFT International recognized the untapped market in human mobile translation. Regardless of industry, the localized translation of websites, marketing content, and social media communication are vital for any organization to succeed on an international scale. Operating out of San Francisco and Beijing, Stepes already has 50,000 professional translators in tow. The app will officially launch on January 5th, making “Big Translation” the newest niche of the on demand app industry.
“The combination of large scale participation in language translation by both businesses and millions of bi-lingual people will create something that Stepes calls, “Big Translation.” Like mobile devices, big data and the Internet are changing the world by creating a sharing economy that thrives on the rapid exchange of content and information, Big Translation will forever change the world’s communications” said the mind behind the cutting edge on demand app.
Stepes creator, Carl Yao, saw limitless potential when he developed the patent-pending chat-based technology. “Stepes is opening the door to international markets for every industry. It enables bilingual people to retail their translation skills globally by instantly matchmaking them with those in need of translation.” Only 250,000 translators currently service the world’s population and with 6,500 spoken languages across the world, the demand far exceeds supply.
Businesses will now be able to have affordable content translated specifically to their industry. This is a major advantage to any field, but especially more technical fields dealing with complex phrasing such as the medical industry. “Doctors can translate medical subjects at a much higher level of accuracy than regular translators because of their technical expertise and familiarity with the field’s terminology. The same is true of any number of industries,” explains Yao.
Click here to read the full article.
About CSOFT Health Sciences
CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com